{"artifact":{"id":"experiment-exp-e6cdf2ea-4518-4cb6-8a05-0fc98103555b","artifact_type":"experiment","entity_ids":"[\"EFNB1, EPHB4, TP53, TP63\"]","title":"Spatial transcriptomic analysis of multistage ESCC development","quality_score":0.85,"created_by":"experiment_extractor","provenance_chain":"[]","content_hash":"f321ce2be3aea590a235614eb91ccc095b8e8c49f6694027ad1bdf735c3630da","metadata":{"_origin":{"url":null,"type":"internal","tracked_at":"2026-04-10T14:38:54.255475"},"p_value":null,"protocol":"spatial transcriptomic sequencing and analysis of multistage ESCC samples","effect_size":null,"sample_size":null,"source_pmid":"38097539","extracted_at":"2026-04-10T07:38:54.252600","_schema_version":1,"experiment_type":"gene_expression","success_criteria":"detection of aberrant epithelial cell interactions and associated signaling pathways","expected_outcomes":"identification of molecular mechanisms triggering EMT and proliferation in epithelial cancer","statistical_methods":null},"created_at":"2026-04-10T14:38:54-07:00","updated_at":"2026-04-10T14:38:54-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-10T14:38:54-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":"ok","contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"3403d5c0-0ec8-43c9-95f3-cc7361a861e0","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"experiment_extractor"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"paper-38097539","link_type":"derives_from","strength":1.0,"evidence":"Extracted from paper abstract/full text"},{"target_artifact_id":"wiki-genes-efnb1","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: EFNB1"},{"target_artifact_id":"wiki-genes-ephb4","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: EPHB4"},{"target_artifact_id":"wiki-proteins-tp53-protein","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: TP53"},{"target_artifact_id":"wiki-mechanisms","link_type":"related","strength":0.54,"evidence":"Reverse: Title match: Mechanisms"},{"target_artifact_id":"wiki-genes-tp53","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: TP53"},{"target_artifact_id":"wiki-diseases-cancer","link_type":"related","strength":0.54,"evidence":"Reverse: Title match: Cancer"}],"incoming_links":[{"source_artifact_id":"wiki-genes-efnb1","link_type":"mentions","strength":0.8,"evidence":"Gene target: EFNB1"},{"source_artifact_id":"wiki-genes-ephb4","link_type":"mentions","strength":0.8,"evidence":"Gene target: EPHB4"},{"source_artifact_id":"wiki-proteins-tp53-protein","link_type":"mentions","strength":0.8,"evidence":"Gene target: TP53"},{"source_artifact_id":"wiki-mechanisms","link_type":"mentions","strength":0.6,"evidence":"Title match: Mechanisms"},{"source_artifact_id":"wiki-genes-tp53","link_type":"mentions","strength":0.8,"evidence":"Gene target: TP53"},{"source_artifact_id":"wiki-diseases-cancer","link_type":"mentions","strength":0.6,"evidence":"Title match: Cancer"},{"source_artifact_id":"wiki-therapeutics-synaptic-plasticity-therapeutics-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/therapeutics-synaptic-plasticity-therapeutics-pd"},{"source_artifact_id":"wiki-therapeutics-cue1-device-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/therapeutics-cue1-device-pd"},{"source_artifact_id":"wiki-therapeutics-ephb-receptor-modulator-therapy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: EFNB1 mentioned 2x in wiki/therapeutics-ephb-receptor-modulator-therapy"},{"source_artifact_id":"wiki-therapeutics-adenosine-a2a-receptor-antagonists-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/therapeutics-adenosine-a2a-receptor-antagonists-pd"},{"source_artifact_id":"wiki-therapeutics-sodium-oligomannate-gv971","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/therapeutics-sodium-oligomannate-gv971"},{"source_artifact_id":"wiki-clinical-trials-ct1-dap001-ips-dopaminergic-progenitors-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-ct1-dap001-ips-dopaminergic-progenitors-pd"},{"source_artifact_id":"wiki-clinical-trials-nct05266417-nose-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-nct05266417-nose-pd"},{"source_artifact_id":"wiki-clinical-trials-apocynin-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-apocynin-pd"},{"source_artifact_id":"wiki-clinical-trials-nct06365190-rtms-pd","link_type":"mentions","strength":0.5,"evidence":"Content: TP53 mentioned 4x in wiki/clinical-trials-nct06365190-rtms-pd"},{"source_artifact_id":"wiki-clinical-trials-nct06954662-amino-acid-supplement-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-nct06954662-amino-acid-supplement-pd"},{"source_artifact_id":"wiki-clinical-trials-ab-1005-gdnf-gene-therapy-regenerate-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-ab-1005-gdnf-gene-therapy-regenerate-pd"},{"source_artifact_id":"wiki-clinical-trials-retigabine-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-retigabine-pd"},{"source_artifact_id":"wiki-clinical-trials-nct07308418-vibrotactile-stimulation-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-nct07308418-vibrotactile-stimulation-pd"},{"source_artifact_id":"wiki-clinical-trials-intranasal-insulin-glutathione-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-intranasal-insulin-glutathione-pd"},{"source_artifact_id":"wiki-clinical-trials-biib122-luma-lrrk2-inhibitor-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-biib122-luma-lrrk2-inhibitor-pd"},{"source_artifact_id":"wiki-clinical-trials-nct06687837-autologous-dopaminergic-neurons-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-nct06687837-autologous-dopaminergic-neurons-pd"},{"source_artifact_id":"wiki-clinical-trials-nct06821230-dyadic-mindfulness-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-nct06821230-dyadic-mindfulness-pd"},{"source_artifact_id":"wiki-clinical-trials-valacyclovir-hsv1-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-valacyclovir-hsv1-pd"},{"source_artifact_id":"wiki-clinical-trials-mr-guided-focused-ultrasound-gcase-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-mr-guided-focused-ultrasound-gcase-pd"},{"source_artifact_id":"wiki-clinical-trials-pde4-inhibitor-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-pde4-inhibitor-pd"},{"source_artifact_id":"wiki-clinical-trials-nouvneu001-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-nouvneu001-pd"},{"source_artifact_id":"wiki-clinical-trials-vibrotactile-coordinated-reset-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-vibrotactile-coordinated-reset-pd"},{"source_artifact_id":"wiki-clinical-trials-bacillus-subtilis-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/clinical-trials-bacillus-subtilis-pd"},{"source_artifact_id":"wiki-datasets-amp-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/datasets-amp-pd"},{"source_artifact_id":"wiki-hypotheses-cellular-senescence-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: TP53 mentioned 6x in wiki/hypotheses-cellular-senescence-parkinsons"},{"source_artifact_id":"wiki-cell-types-globus-pallidus-internus-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/cell-types-globus-pallidus-internus-pd"},{"source_artifact_id":"wiki-cell-types-nigrostriatal-dopamine-terminals-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/cell-types-nigrostriatal-dopamine-terminals-pd"},{"source_artifact_id":"wiki-cell-types-melanocytes-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/cell-types-melanocytes-pd"},{"source_artifact_id":"wiki-cell-types-snc-dopamine-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/cell-types-snc-dopamine-pd"},{"source_artifact_id":"wiki-cell-types-dopaminergic-vta-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/cell-types-dopaminergic-vta-pd"},{"source_artifact_id":"wiki-cell-types-dorsal-raphe-serotonergic-neurons-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/cell-types-dorsal-raphe-serotonergic-neurons-pd"},{"source_artifact_id":"wiki-cell-types-vulnerable-dopaminergic-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/cell-types-vulnerable-dopaminergic-pd"},{"source_artifact_id":"wiki-cell-types-synaptic-boutons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/cell-types-synaptic-boutons"},{"source_artifact_id":"wiki-mechanisms-astrocyte-senescence-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: TP53 mentioned 4x in wiki/mechanisms-astrocyte-senescence-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-thioflavin-t-aggregation-assay","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/mechanisms-thioflavin-t-aggregation-assay"},{"source_artifact_id":"wiki-mechanisms-mlcs-quantification-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/mechanisms-mlcs-quantification-pd"},{"source_artifact_id":"wiki-mechanisms-ephrin-ephr-receptor-signaling-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: EFNB1 mentioned 4x in wiki/mechanisms-ephrin-ephr-receptor-signaling-pathway"},{"source_artifact_id":"wiki-mechanisms-p53-parkinson-disease","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/mechanisms-p53-parkinson-disease"},{"source_artifact_id":"wiki-technologies-digital-therapeutics-pd","link_type":"mentions","strength":0.5,"evidence":"Content: TP53 mentioned 4x in wiki/technologies-digital-therapeutics-pd"},{"source_artifact_id":"wiki-technologies-digital-biomarkers-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/technologies-digital-biomarkers-pd"},{"source_artifact_id":"wiki-technologies-wearable-sensors-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/technologies-wearable-sensors-pd"},{"source_artifact_id":"wiki-technologies-ai-movement-analysis-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/technologies-ai-movement-analysis-pd"},{"source_artifact_id":"wiki-biomarkers-alpha-synuclein-seed-kinetics-pd","link_type":"mentions","strength":0.5,"evidence":"Content: TP53 mentioned 4x in wiki/biomarkers-alpha-synuclein-seed-kinetics-pd"},{"source_artifact_id":"wiki-entities-tumor-necrosis-factor","link_type":"mentions","strength":0.5,"evidence":"Content: TP53 mentioned 3x in wiki/entities-tumor-necrosis-factor"},{"source_artifact_id":"wiki-experiments-alpha-synuclein-aggregation-triggers-sporadic-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/experiments-alpha-synuclein-aggregation-triggers-sporadic-pd"},{"source_artifact_id":"wiki-experiments-glp1-responder-prediction-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/experiments-glp1-responder-prediction-pd"},{"source_artifact_id":"wiki-experiments-alpha-syn-saa-kinetics-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/experiments-alpha-syn-saa-kinetics-pd"},{"source_artifact_id":"wiki-experiments-synaptic-mitochondrial-resilience-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/experiments-synaptic-mitochondrial-resilience-pd"},{"source_artifact_id":"wiki-experiments-alpha-synuclein-spreading-neurodegeneration-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/experiments-alpha-synuclein-spreading-neurodegeneration-pd"},{"source_artifact_id":"wiki-experiments-combination-therapy-sequencing-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/experiments-combination-therapy-sequencing-pd"},{"source_artifact_id":"wiki-experiments-dopaminergic-neuron-selective-vulnerability-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/experiments-dopaminergic-neuron-selective-vulnerability-pd"},{"source_artifact_id":"wiki-chemotherapy-resistance","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: TP53 mentioned 2x in wiki/chemotherapy-resistance"},{"source_artifact_id":"open_question-819f992d-4971-496f-bbbd-124c8684e555","link_type":"discriminating_experiment","strength":0.78,"evidence":"{\"confidence\": 0.78, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"}],"current_artifact_id":"experiment-exp-e6cdf2ea-4518-4cb6-8a05-0fc98103555b","is_canonical":true,"supersede_chain":["experiment-exp-e6cdf2ea-4518-4cb6-8a05-0fc98103555b"]}